Tissue Engineering And Nanotheranostics

(Steven Felgate) #1
b2815 Tissue Engineering and Nanotheranostics “9.61x6.69”

268 Tissue Engineering and Nanotheranostics



  1. Shen J, He Q, Gao Y, Shi J, Li Y. Mesoporous silica nanoparticles load­
    ing doxorubicin reverse multidrug resistance: Performance and mecha­
    nism. Nanoscale 3 , 4314–4322 (2011).

  2. Pan L, Liu J, He Q, Wang L, Shi J. Overcoming multidrug resistance
    of cancer cells by direct intranuclear drug delivery using TAT­
    conjugated mesoporous silica nanoparticles. Biomaterials 34 , 2719–
    2730 (2013).

  3. Lee JE, Lee N, Kim H, Kim J, Choi SH, Kim JH, Kim T, Song IC,
    Park SP, Moon WK, Hyeon T. Uniform mesoporous dye­doped silica
    nanoparticles decorated with multiple magnetite nanocrystals for
    simultaneous enhanced magnetic resonance imaging, fluorescence
    imaging, and drug delivery. J. Am. Chem. Soc. 132 , 552–557 (2010).

  4. Lee JE, Lee N, Kim T, Kim J, Hyeon T. Multifunctional mesoporous
    silica nanocomposite nanoparticles for theranostic applications. Acc.
    Chem. Res. 44 , 893–902 (2011).

  5. Chen Y, Yin Q, Ji X, Zhang S, Chen H, Zheng Y, Sun Y, Qu H, Wang
    Z, Li Y, Wang X, Zhang K, Zhang L, Shi J. Manganese oxide­based
    multifunctionalized mesoporous silica nanoparticles for pH­responsive
    MRI, ultrasonography and circumvention of MDR in cancer cells.
    Biomaterials 33 , 7126–7137 (2012).

  6. Xue S, Wang Y, Wang M, Zhang L, Du X, Gu H, Zhang C. Iodinated
    oil­loaded, fluorescent mesoporous silica­coated iron oxide nanoparti­
    cles for magnetic resonance imaging/computed tomography/fluores­
    cence trimodal imaging. Int. J. Nanomed. 9 , 2527–2538 (2014).

  7. Chen F, Hong H, Zhang Y, Valdovinos HF, Shi S, Kwon GS, Theuer
    CP, Barnhart TE, Cai W. In vivo tumor targeting and image­guided
    drug delivery with antibody­conjugated, radiolabeled mesoporous
    silica nanoparticles. ACS Nano. 7 , 9027–9039 (2013).

  8. Chen F, Nayak TR, Goel S, Valdovinos HF, Hong H, Theuer CP,
    Barnhart TE, Cai W. In vivo tumor vasculature targeted PET/NIRF
    imaging with TRC105(Fab)­conjugated, dual­labeled mesoporous
    silica nanoparticles. Mol. Pharm. 11 , 4007–4014 (2014).

  9. Kempen PJ, Greasley S, Parker KA, Campbell JL, Chang HY, Jones
    JR, Sinclair R, Gambhir SS, Jokerst JV. Theranostic mesoporous silica
    nanoparticles biodegrade after pro­survival drug delivery and ultra­
    sound/magnetic resonance imaging of stem cells. Theranostics 5 ,
    631–642 (2015).

  10. Chen Y, Chen H, Shi J. In vivo bio­safety evaluations and diagnostic/
    therapeutic applications of chemically designed mesoporous silica
    nanoparticles. Adv. Mater. 25 , 3144–3176 (2013).

Free download pdf